Corteva, Inc. reported a net loss of $308 million for the third quarter ended September 30, 2025, on top of a $2.618 billion in net sales and a GAAP earnings‑per‑share loss of $0.46. The company’s operating EBITDA for the quarter was $49 million, a turnaround from the $100 million operating‑EBITDA loss recorded in Q3 2024.
The adjusted earnings‑per‑share loss of $0.23 beat the consensus estimate of a $0.49 loss by $0.26, a surprise of more than 50 %. The beat was driven by disciplined cost management and a favorable mix shift toward higher‑margin crop‑protection products, which offset the impact of raw‑material price increases. Revenue of $2.618 billion exceeded the consensus estimate of $2.49 billion by $128 million, a 5 % beat, largely due to a 12 % volume lift across both seed and crop‑protection segments.
Segment performance highlighted a 33 % year‑over‑year rise in seed sales to $917 million, powered by strong demand for new hybrid varieties, and a 4 % increase in crop‑protection sales to $1.70 billion, supported by the launch of new biological products. The seed segment’s higher price/mix contributed to a 4 % lift in operating‑EBITDA margin, while the crop‑protection segment saw a 135‑basis‑point improvement in margin year‑over‑year.
Compared with Q3 2024, Corteva’s net loss narrowed from $519 million to $308 million, and operating EBITDA swung from a $100 million loss to a $49 million gain, reflecting both revenue growth and the effectiveness of the company’s “controlling the controllables” program.
Management raised full‑year 2025 operating‑EBITDA guidance to $3.8 billion–$3.9 billion and operating EPS guidance to $3.25–$3.35, while reaffirming a net‑sales target of $17.7 billion–$17.9 billion. The upward revision signals confidence that demand will remain robust in the second half of the year and that cost‑control initiatives will continue to deliver margin expansion.
CEO Chuck Magro said, “We delivered a strong third quarter across the company, reinforcing our conviction that our two businesses will continue to thrive as independent public companies.” He added, “In the second quarter, farmers’ drive to get the most out of every acre led to higher demand for our best‑in‑class seed and crop‑protection solutions.”
Investors responded positively to the earnings beat and guidance raise, reflecting confidence in Corteva’s ability to sustain growth and improve profitability through disciplined cost management and a favorable product mix.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.